Kezar Life Sciences (KZR) Total Debt (2021 - 2025)
Historic Total Debt for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $6.7 million.
- Kezar Life Sciences' Total Debt fell 3516.86% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 3516.86%. This contributed to the annual value of $10.3 million for FY2024, which is 257.23% up from last year.
- According to the latest figures from Q3 2025, Kezar Life Sciences' Total Debt is $6.7 million, which was down 3516.86% from $7.9 million recorded in Q2 2025.
- In the past 5 years, Kezar Life Sciences' Total Debt ranged from a high of $10.3 million in Q4 2024 and a low of $6.7 million during Q3 2025
- For the 5-year period, Kezar Life Sciences' Total Debt averaged around $9.6 million, with its median value being $9.9 million (2022).
- In the last 5 years, Kezar Life Sciences' Total Debt soared by 257.23% in 2024 and then plummeted by 3516.86% in 2025.
- Kezar Life Sciences' Total Debt (Quarter) stood at $9.6 million in 2021, then grew by 2.2% to $9.8 million in 2022, then rose by 2.39% to $10.1 million in 2023, then rose by 2.57% to $10.3 million in 2024, then tumbled by 35.58% to $6.7 million in 2025.
- Its Total Debt was $6.7 million in Q3 2025, compared to $7.9 million in Q2 2025 and $9.1 million in Q1 2025.